What role do patient advocacy groups play in promoting cannabis-related research for AS?
Patient advocates have become an essential force in shaping rheumatology research, especially around cannabis for ankylosing spondylitis. These groups push for more inclusive study designs, raise awareness of unmet needs, and amplify patient voices in medical and political arenas. Their work ensures that lived experience becomes a recognised part of research planning.
Through strategic advocacy efforts, these organisations have influenced everything from trial recruitment to policy lobbying. They’re also embracing technology use to collect real-world data, connect patient communities, and streamline participation in research. The ultimate goal? Advancing future applications that reflect what patients need and want from cannabis-based care.
How Advocacy Shapes Research
Here are key ways advocacy groups support progress in rheumatology research:
Influencing funding decisions
By highlighting research gaps, advocacy organisations attract resources and public interest.
Improving trial access
Groups help patients navigate entry into trials and advocate for broader inclusion criteria.
Leveraging digital platforms
Tech tools amplify advocacy efforts and make technology use a cornerstone of patient-led research.
Shaping future study priorities
Real-life insights help guide future applications that are clinically relevant and patient-centred.
Visit providers like LeafEase to connect with networks that are championing patient-led rheumatology research.
For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Ankylosing Spondylitis and medical cannabis.
